Rong Tang
HuaXiu Road 19th
Haikou, 570311, China
Haikou, 570311, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Retraction Note: CD142 promotes trophoblast cell migration by inhibiting BCL2-related autophagic degradation of IL-8.
Journal: In vitro cellular & developmental biology. Animal
Published: October 02, 2025
Circ_0081343 promotes autophagy and alleviates pyroptosis via PI3 K/AKT/HIF-1α axis in hypoxia-induced fetal growth restriction of mice.
Journal: Animal cells and systems
Published: May 12, 2025
Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE After Biliary Drainage: TEMP Score.
Journal: Journal of hepatocellular carcinoma
Published: November 13, 2024
Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma: Sorafenib Plus TACE vs TACE Alone Randomized Clinical Trial.
Journal: JAMA oncology
Published: June 20, 2024
Circular RNA hsa_circ_0081343 modulates trophoblast autophagy through Rbm8a nuclear translocation.
Journal: Placenta
Published: June 06, 2024
Correction: CD142 promotes trophoblast cell migration by inhibiting BCL2-related autophagic degradation of IL-8.
Journal: In vitro cellular & developmental biology. Animal
Published: November 29, 2023
DEB-TACE versus cTACE for unresectable HCC with B1-type bile duct invasion after successful biliary drainage: A propensity score matching analysis.
Journal: Cancer medicine
Published: October 19, 2023
Secukinumab plays a synergistic role with starvation therapy in promoting autophagic cell death of hepatocellular carcinoma via inhibiting IL-17A-increased BCL2 level.
Journal: In vitro cellular & developmental biology. Animal
Published: January 30, 2023
CD142 promotes trophoblast cell migration by inhibiting BCL2-related autophagic degradation of IL-8.
CD142 promotes trophoblast cell migration by inhibiting BCL2-related autophagic degradation of IL-8.
Journal: In vitro cellular & developmental biology. Animal
Published: December 07, 2022
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 03, 2022
Last Updated: 09/26/2026